Four distinct molecules
Each component acts on its own targets; the blend has no single unified mechanism, and published work on each component does not transfer to the mixture.
These are results measured on this lot. Full material specification is in Know your compound.
Regenerative Blend
A four-component blend of KPV, GHK-Cu, BPC-157 and TB-500 in a single vial.
$70.00 per vial with BOGO
Research use only — not for human or veterinary use, diagnostic or therapeutic.
Know your compound
KLOW is not a single peptide — it is a blend of four separate compounds supplied together in one vial: KPV, GHK-Cu, BPC-157 and TB-500. Each is an independently characterised molecule with its own published literature, and each is assayed as part of the lot release.
The formulation combines two tripeptides (KPV and the copper complex GHK-Cu) with two longer chains (the 15-residue BPC-157 and the thymosin β4 fragment sold as TB-500). Researchers use blends of this kind to study combinations that would otherwise require reconstituting four vials separately; the literature on the combination itself is far thinner than the literature on each component.
Reflex supplies KLOW as a lyophilized powder for laboratory research use only. Component ratios are stated on the lot Certificate of Analysis. Nothing here describes an approved therapy or a use in humans.
Blend ratio is stated on the lot Certificate of Analysis.
What the molecule is.
How we know the material matches the label.
What arrives, and how it is kept.
What the literature examines
Summaries of what published research has investigated. Preclinical unless stated otherwise — not claims about this product.
Each component acts on its own targets; the blend has no single unified mechanism, and published work on each component does not transfer to the mixture.
BPC-157 and TB-500 dominate the regenerative-peptide literature; KPV and GHK-Cu are studied in inflammatory and matrix-remodelling contexts respectively.
Certificate of Analysis
Not a brand-wide spec sheet — a lot-specific certificate from an independent laboratory, published before the lot ships and searchable by lot number forever.
Independent U.S. laboratory
Certificate of Analysis · RFX-2606-053
| Test | Specification | Result |
|---|---|---|
| Purity (HPLC) | ≥ 99.0% | 99.4% |
| Identity (LC-MS) | Conforms | Conforms |
| Appearance | White powder | Conforms |
| Net content | Label claim | Conforms |
Questions
No. KLOW is not an FDA-approved drug and is not approved for human or veterinary use. It is supplied exclusively as a research material for laboratory use, and it is not intended to diagnose, treat, cure, or prevent any disease.
Yes. Every lot is assayed by an independent U.S. laboratory for purity and identity, and the certificate for the lot you receive is published in our COA library — you can read it before you order.
Purity is quantified by reverse-phase HPLC against a reference standard, and identity is confirmed by mass spectrometry. Both results appear on the lot certificate.
Lyophilized material is typically stored cold and protected from light. Handling and storage are the responsibility of the receiving laboratory; refer to the lot documentation for specifics.
Every second vial is free, sitewide and automatically. Add two vials and you pay for one; add six and you pay for three. Compounds can be mixed, there is no code, and there is no limit.
Orders are processed promptly and shipped with tracking. Free US shipping applies over $100; Priority shipping is $8.95 otherwise.
The guarantee
Have any lot independently re-tested. If the results don't match the purity printed on its published certificate, we refund the order in full — no returns, no argument.
Same research area